UBS Group’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.66K | Buy |
1,025
+314
| +44% | +$1.73K | ﹤0.01% | 7828 |
|
|
2025
Q1 | $4.1K | Buy |
711
+361
| +103% | +$2.08K | ﹤0.01% | 7831 |
|
|
2024
Q4 | $3.24K | Sell |
350
-106
| -23% | -$981 | ﹤0.01% | 7661 |
|
|
2024
Q3 | $7.49K | Sell |
456
-371
| -45% | -$6.09K | ﹤0.01% | 6691 |
|
|
2024
Q2 | $15.8K | Sell |
827
-74
| -8% | -$1.41K | ﹤0.01% | 6305 |
|
|
2024
Q1 | $24.1K | Buy |
901
+379
| +73% | +$10.1K | ﹤0.01% | 5668 |
|
|
2023
Q4 | $7.15K | Sell |
522
-453
| -46% | -$6.2K | ﹤0.01% | 6436 |
|
|
2023
Q3 | $15.1K | Sell |
975
-330
| -25% | -$5.11K | ﹤0.01% | 5802 |
|
|
2023
Q2 | $28.2K | Buy |
1,305
+244
| +23% | +$5.27K | ﹤0.01% | 5672 |
|
|
2023
Q1 | $18.9K | Buy |
1,061
+175
| +20% | +$3.11K | ﹤0.01% | 6036 |
|
|
2022
Q4 | $15K | Buy |
886
+55
| +7% | +$930 | ﹤0.01% | 6835 |
|
|
2022
Q3 | $27K | Buy |
831
+54
| +7% | +$1.76K | ﹤0.01% | 5920 |
|
|
2022
Q2 | $44K | Buy |
777
+14
| +2% | +$793 | ﹤0.01% | 5007 |
|
|
2022
Q1 | $45K | Buy |
763
+528
| +225% | +$31.1K | ﹤0.01% | 5580 |
|
|
2021
Q4 | $17K | Buy |
235
+232
| +7,733% | +$16.8K | ﹤0.01% | 6952 |
|
|
2021
Q3 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 8642 |
|
|
2021
Q2 | $0 | Sell |
2
-175
| -99% | – | ﹤0.01% | 8475 |
|
|
2021
Q1 | $21K | Sell |
177
-467
| -73% | -$55.4K | ﹤0.01% | 6320 |
|
|
2020
Q4 | $84K | Buy |
644
+640
| +16,000% | +$83.5K | ﹤0.01% | 4816 |
|
|
2020
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 7289 |
|
|
2020
Q2 | – | Sell |
-763
| Closed | -$339K | – | 7237 |
|
|
2020
Q1 | $339K | Buy |
763
+717
| +1,559% | +$319K | ﹤0.01% | 3521 |
|
|
2019
Q4 | $31K | Sell |
46
-158
| -77% | -$106K | ﹤0.01% | 5561 |
|
|
2019
Q3 | $75K | Buy |
204
+84
| +70% | +$30.9K | ﹤0.01% | 5015 |
|
|
2019
Q2 | $22K | Buy |
+120
| New | +$22K | ﹤0.01% | 5674 |
|